Skip to content

NCEL

NewCelX Ltd.

NASDAQ · Healthcare · Biotechnology · CH

$2.63
+5.20%
Ask drillr

Next report

Analyst consensus

Next report date
Mar 3, 2027
EPS estimate
-$0.65
Revenue estimate
—

Latest reported

Last report date
Sep 18, 2026
EPS actual
-$0.53
EPS estimate
-$0.53
Revenue actual
—
Revenue estimate
—

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
0
EPS in line (12Q)
1
Avg surprise (4Q)
+73.5%
Revenue beats (12Q)
—
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Sep 18, 2026-$0.53-$0.53In line—
May 15, 2024-$8.40-$0.00Beat 100.00%—
May 5, 2023-$12-$0.29Beat 97.55%—
Oct 11, 2022—-$0.54——
Mar 24, 2022-$14-$0.50Beat 96.39%—
May 14, 2021-$6.80-$0.34Beat 95.03%—
Jun 29, 2019—-$0.31——

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 3, 2027